Skip to main content
. 2021 Sep 23;26(12):1006–e2129. doi: 10.1002/onco.13949
Title Safety
Number of Patients Screened 14
Number of Patients Enrolled 14
Number of Patients Evaluable for Toxicity 12
Number of Patients Evaluated for Efficacy 12
Evaluation Method Occurrences of adverse events
Outcome Notes Fractures rates were 0 out of 12 participants